| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $473.3M | +24.2% |
| Cost of Revenue | $449.7M | +19.1% |
| Gross Profit | $23.6M | +569.9% |
| R&D Expense | $40.3M | -15.2% |
| SG&A Expense | $69.1M | -14.8% |
| Operating Income | -$104.5M | +16.4% |
| Pre-tax Income | -$111.4M | -11.8% |
| Income Tax | -$192K | -425.4% |
| Net Income | -$115.3M | +9.8% |
| EPS (Basic) | -$0.61 | +14.1% |
| EPS (Diluted) | -$0.61 | +14.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.8M | -36.8% |
| Accounts Receivable | $33.2M | +16.2% |
| Inventory | $25.5M | -58.9% |
| Current Assets | $118.9M | -60.5% |
| Total Assets | $274.8M | -45.1% |
| Current Liabilities | $101.9M | +10.2% |
| Long-term Debt | $60.5M | -43.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.1M | +21.7% |
| Capital Expenditures | $11.8M | -28.7% |
| Investing Cash Flow | $118.0M | +393.3% |
| Financing Cash Flow | -$72.1M | -173.6% |
| Free Cash Flow | -$84.9M | +22.7% |
| Total Liabilities |
| $188.7M |
| -38.5% |
| Stockholders' Equity | $86.0M | -55.6% |